Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Thompson

Showing results (421-430 of 569) with videos related to

Pageof 57
Sort By:
The Lancet. Oncology|July 25, 2015
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialMichael A Henderson, Bryan H Burmeister, Jill Ainslie, et al.
The Australasian Journal of Dermatology|October 11, 2018
The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and managementPascale Guitera, Helena Collgros, Christine M Madronio, et al.
Journal of the American Academy of Dermatology|December 12, 2022
Melanomas in children and adolescents: Clinicopathologic features and survival outcomesMary-Ann El Sharouni, Robert V Rawson, Alison J Potter, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 5, 2022
Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)Alistair J Cochran, Duan-Ren Wen, Rong-Rong Huang, et al.
Future Oncology (London, England)|February 10, 2023
Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publicationMary-Ann El Sharouni, Serigne N Lo, Alexander Hr Varey, et al.
Australian Journal of General Practice|June 21, 2019
Improving diagnostic accuracy for suspicious melanocytic skin lesions: New Australian melanoma clinical practice guidelines stress the importance of clinician/pathologist communicationRichard Scolyer, H Peter Soyer, John W Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanomaBruce Elliott, Richard A Scolyer, Stefan Suciu, et al.
Nature Genetics|January 15, 2008
Genome-wide scan identifies variation in MLXIPL associated with plasma triglyceridesJaspal S Kooner, John C Chambers, Carlos A Aguilar-Salinas, et al.
Annals of Surgery|September 2, 2005
Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trialDonald L Morton, Alistair J Cochran, John F Thompson, et al.
Annals of Surgical Oncology|January 4, 2021
Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D MelanomaRobin M Turner, Mbathio Dieng, Nikita Khanna, et al.
Pageof 57

Showing results (421-430 of 569) with videos related to

Sort By:
Pageof 57
The Lancet. Oncology|July 25, 2015
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialMichael A Henderson, Bryan H Burmeister, Jill Ainslie, et al.
The Australasian Journal of Dermatology|October 11, 2018
The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and managementPascale Guitera, Helena Collgros, Christine M Madronio, et al.
Journal of the American Academy of Dermatology|December 12, 2022
Melanomas in children and adolescents: Clinicopathologic features and survival outcomesMary-Ann El Sharouni, Robert V Rawson, Alison J Potter, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 5, 2022
Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)Alistair J Cochran, Duan-Ren Wen, Rong-Rong Huang, et al.
Future Oncology (London, England)|February 10, 2023
Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return: a plain language summary of publicationMary-Ann El Sharouni, Serigne N Lo, Alexander Hr Varey, et al.
Australian Journal of General Practice|June 21, 2019
Improving diagnostic accuracy for suspicious melanocytic skin lesions: New Australian melanoma clinical practice guidelines stress the importance of clinician/pathologist communicationRichard Scolyer, H Peter Soyer, John W Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanomaBruce Elliott, Richard A Scolyer, Stefan Suciu, et al.
Nature Genetics|January 15, 2008
Genome-wide scan identifies variation in MLXIPL associated with plasma triglyceridesJaspal S Kooner, John C Chambers, Carlos A Aguilar-Salinas, et al.
Annals of Surgery|September 2, 2005
Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trialDonald L Morton, Alistair J Cochran, John F Thompson, et al.
Annals of Surgical Oncology|January 4, 2021
Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D MelanomaRobin M Turner, Mbathio Dieng, Nikita Khanna, et al.
Pageof 57